SIRT1 and breast cancer: These results mean that SIRT1 translocation into the nucleus is not necessary in bL-NQO1-induced cell death, suggesting that there is an alternative cell-death pathway induced by bL-NQO1 in breast-cancer, although many reports suggest that the NAD–SIRT1 axis could be a key suppressor in cancer proliferation and survival.